Skip to main content
SpringerLink
Log in

Cyclosporin A

Pharmacology and Therapeutic Use in Autoimmune Diseases

  • Chapter
Immunopharmacology in Autoimmune Diseases and Transplantation

Abstract

Cyclosporin A (CyA, Sandimmun®, Sandoz) is a potent immunosuppressive agent. First trials in human transplantation started in 1978, and since that time very wide experience has been gained in its use (Beveridge, 1986). It is now considered a reference treatment, especially for liver and heart transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Assan, R., Feutren, G., Debray-Sachs, M., Quiniou-Debrie, M. C., Laborie, C., Thomas, G., Chatenoud, M., and Bach, J. E., 1985, Metabolie and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus, Lancet 1:67–71.

    Article  PubMed  CAS  Google Scholar 

  • Autenried, P., and Halloran, P. E., 1985, Cyclosporine blocks the induction of Class I and Class IIMHC products in mouse kidney by Graft-VS-Host disease, J. Immunol. 135:3922–3928.

    PubMed  CAS  Google Scholar 

  • Bach, J. E., 1988, Mechanisms of autoimmunity in insulin-dependent diabetes mellitus, Clin. Exp. Immunol. 72:1–8.

    PubMed  CAS  Google Scholar 

  • Ben Ezra, D., 1986, Cyclosporin A in Behçet’s disease—An overview, in: Recent Advances in Behget’s Disease (T. Lehner and C. G. Barnes, eds.), Royal Society of Medical Service, London, pp. 319–325.

    Google Scholar 

  • Ben Ezra, D., Cohen, E., Rakotomalala, M., de Courten, C., Harris, W., Chajek, T., Friedman, G., and Matamoros, N., 1988a, Treatment of endogenous uveitis with cyclosporin A, Transplant. Proc. 20(Suppl. 4):122–127.

    Google Scholar 

  • Ben Ezra, D., Nussenblatt, R. B., and Timonen, P. (eds.), 1988b, Optimal use of Sandimmun® in endogenous uveitis, Springer-Verlag, Berlin.

    Google Scholar 

  • Beveridge, T., 1986, Clinical transplantation—Overview, Prog. Allergy 38:269–292.

    PubMed  CAS  Google Scholar 

  • Bolton, C., Borel, J. E., Cuzner, M. L., Davison, A. N., and Turner, A. M., 1982, Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis, J. Neurol. Sci. 56:147–153.

    Article  PubMed  CAS  Google Scholar 

  • Borel, J. E., and Gunn, H., 1986, Cyclosporine as a new approach to therapy, Ann. NY Acad. Sci. 475:307–319.

    Article  PubMed  CAS  Google Scholar 

  • Borel, J. E., Feurer, C., Gubler, H. U., and Stähelin, H., 1976, Biological effects of cyclosporin A: A new antilymphocyte agent, Agents Actions 6:468–475.

    Article  PubMed  CAS  Google Scholar 

  • Brabant, G., Peter, H., Becker, H., Schwarzrock, R., Wonigeit, K., and Hesch, R. D., 1984, Cyclosporine in infiltrative eye disease, Lancet 1:515–516.

    Article  PubMed  CAS  Google Scholar 

  • Brodehl, J., Hoyer, P. F., Oemar, B. S., Helmchen, U., and Wonigeit, K., 1988, Cyclosporin treatment of nephrotic syndrome in children, Transplant. Proc. 20(Suppl. 4):269–274.

    PubMed  CAS  Google Scholar 

  • Brynskov, J., Freund, L., Rasmussen, S. N., Lauritsen, K., Schaffalitsky de Muckadell, O., Williams, N., MacDonald, A. S., Tanton, R., Molina, E., Campanini, M. C., Bianchi, P., Ranzi, T., Quarto di Palo, E., Malchow-Moller, A., Thomsen, O. O., Tage-Jensen, U., Binder, V, and Riis, P., 1989, A placebo-controlled, double-blind randomized trial of cyclosporine therapy in active chronic Crohn’s disease, N. Engl. J. Med. 321:845–850.

    Article  PubMed  CAS  Google Scholar 

  • Canadian-European Randomized Control Trial Group, 1988, Induction of remission of type 1 diabetes mellitus by cyclosporin is dependent on early intervention and associated with maintained enhancement of insulin secretion through one year of treatment, Diabetes 37:1574–1582.

    Article  Google Scholar 

  • Cockburn, I., and Krupp, P., 1989a, An appraisal of drug interactions with Sandimmun®, Transplant Proc. 21:3845–3850.

    PubMed  CAS  Google Scholar 

  • Cockburn, I. T. R., and Krupp, P., 1989b, The risk of neoplasms in patients treated with cyclosporine, J. Autoimmunity 2:723–731.

    Article  CAS  Google Scholar 

  • Critical issues in cyclosporin monitoring: Report on the task force on cyclosporin monitoring, 1987, Clin. Chem. 33:1269–1288.

    Google Scholar 

  • Dieterle, A., Abeywickrama, K., and von Graffenried, B., 1988, Nephrotoxicity and hypertension in patients with autoimmune diseases treated with cyclosporine, Transplant Proc. 20(Suppl. 4):349–355.

    PubMed  CAS  Google Scholar 

  • DiPadova, E., 1989, Pharmacology of cyclosporine (Sandimmune). Pharmacological effect on immune function: In vitro studies, Pharmacol. Rev. 41:373–405.

    CAS  Google Scholar 

  • Dougados, M., Amor, B., 1987, Cyclosporin A in rheumatoid arthritis: Preliminary clinical results of an open trial, Arthritis Rheum. 30:83–87.

    Article  PubMed  CAS  Google Scholar 

  • Dougados, M., Awada, H., and Amor, B., 1988, Cyclosporin in rheumatoid arthritis: A double-blind controlled study in 52 patients, Ann. Rheum. Dis. 47:127–133.

    Article  PubMed  CAS  Google Scholar 

  • Drachman, D. B., Adams, R. N., McKintosh, K., Pestrank, A., 1985, Treatment of experimental myasthenia gravis with cyclosporin A, Clin. Immunol Immunopathol. 34:174–188.

    Article  PubMed  CAS  Google Scholar 

  • Drosos, A. A., Skopouli, E N., Costopoulos, J. S., Papadimitriou, C. S., and Moutsopoulos, M. H., 1986, Cyclosporin A in primary Sjögren’s syndrome: A double-blind study, Ann. Rheum. Dis. 45:731–735.

    Article  Google Scholar 

  • Eisenbarth, G. S., 1986, Type 1 diabetes mellitus. A chronic autoimmune disease, N. Engl. J. Med. 314:1360–1368.

    Article  PubMed  CAS  Google Scholar 

  • Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., Ellis-Madu, M., Duell, E., Annesley, T. M., Cooper, K. D., and Voorhees, J. J., 1991, Cyclosporine for plaque-type psoriasis: Results of a multidose, double-blind trial, N. Engl. J. Med. 324:277–284.

    Article  PubMed  CAS  Google Scholar 

  • Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., and Crabtree, G. R., 1989, Cyclosporine A specifically inhibits function of nuclear proteins involved in T cell activation, Science 246:1617–1620.

    Article  PubMed  CAS  Google Scholar 

  • Feutren, G., 1988, Functional consequences and risk factors of chronic cyclosporin nephrotoxicity in type 1 diabetes trials, Transplant. Proc. 20(Suppl. 4):356–366.

    PubMed  CAS  Google Scholar 

  • Feutren, G., and Mihatsch, M. J., 1992, Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases, N. Engl J. Med. 326:1654–1660.

    Article  PubMed  CAS  Google Scholar 

  • Feutren, G., Papoz, L., Assan, R., Vialettes, B., Karsenty, G., Vexiau, P., Du Rostu, H., Rodier, M., Sirmai, J., Lallemand, A., and Bach, J. F., 1986, Cyclosporine increases the rate and length of remissions in insulin-dependent diabetes of recent onset, Lancet 2:119–124.

    Article  PubMed  CAS  Google Scholar 

  • Feutren, G., Querin, S., Noel, L. H., Chatenoud, L., Beaurain, G., Tron, F., Lesavre, P., and Bach, J. E., 1987, Effects of cyclosporine in severe systemic lupus erythematosus, J. Pediatr. 111:1063–1068.

    Article  PubMed  CAS  Google Scholar 

  • Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., and Schmid, F. X., 1989, Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins, Nature 337:476–478.

    Article  PubMed  CAS  Google Scholar 

  • Førre, O., Bjerkjoel, E., Salversen, G. E., Berg, K. J., Rugstad, H. E., Saelid, G., Mellbye, O. J., and Käss, E., 1987, An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: A preliminary report, Arthritis Rheum. 30:88–92.

    Article  PubMed  Google Scholar 

  • Frickhofen, N., Kaltwasser, J. P., Schrezenmeier, H., et al., 1991, Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine, N. Engl. J. Med. 324:1297–1304.

    Article  PubMed  CAS  Google Scholar 

  • Furue, M, and Katz, S. I., 1988, The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell function of epidermal Langerhans cells in vitro, J. Immunol. 140:4139–4143.

    PubMed  CAS  Google Scholar 

  • Heckmatt, J., Hasson, N., Saunders, C., Thompson, N., Peters, A. M., Cambridge, G., Rose, M., Hyde, S. A., and Dubowitz, V, 1989, Cyclosporin in juvenile dermatomyositis, Lancet 1:1063–1066.

    Article  PubMed  CAS  Google Scholar 

  • Handschumacher, R. E., Harding, M. W., Rice, J., and Drugge, R. J., 1984, Cyclophilin: A specific cytosolic binding protein for cyclosporin A, Science 226:544–547.

    Article  PubMed  CAS  Google Scholar 

  • Herrmann, B., and Müller, W., 1979, Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunosup-pressivum, Akt. Rheumatol. 4:173–186.

    Google Scholar 

  • Hess, A. D, and Colombani, P. M., 1986, Mechanism of action of cyclosporin: In vitro studies, Prog. Allergy 38:198–221.

    PubMed  CAS  Google Scholar 

  • Higgins, E., Munro, C., Marks, J., Friedmann, P. S., and Shuster, S., 1989, Relapse rates in moderately severe chronic psoriasis treated with cyclosporin A, Br. J. Dermatol. 121:71–74.

    Article  PubMed  CAS  Google Scholar 

  • International Kidney Biopsy Registry of Cyclosporine A (Sandimmun®) in Autoimmune Diseases, 1990, Kidney biopsies in control or cyclosporin A-treated psoriatic patients, Br. J.J. Dermatol. 122(Suppl. 36):95–100.

    Google Scholar 

  • Israel-Biet, D, Noel, L. H., Bach, M. A., Dardenne, M., and Bach, J. E., 1983, Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated NZB X NZW) Fl mice, Clin. Exp. Immunol. 54:359–563.

    PubMed  CAS  Google Scholar 

  • Janco, R. L., and English, D., 1983, Cyclosporin and human neutrophil function, Transplantation 35:501–503.

    Article  PubMed  CAS  Google Scholar 

  • Kahan, B. D., 1985, Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters, Transplantation 40:457–476.

    Article  PubMed  CAS  Google Scholar 

  • Kappos, L., Patzold, U., Dommasch, D., Poser, S., Haas, J., Krauseneck, P., Malin, J. P., Fierz, W., vonGraffenried, B., and Gugerli, U. S., 1988, Cyclosporin vs. azathioprine in the long-term treatment of multiple sclerosis—results of the German multicenter study, Ann. Neurol 23:56–63.

    Article  PubMed  CAS  Google Scholar 

  • Kato, N., Halprin, K. M., Taylor, J. R., Ohkawara, A., 1988, Cyclosporin A induced augmentation of the beta-adrenergic adenylate cyclase response of pig epidermis, Arch. Dermatol. Res., 280:89–92.

    Article  PubMed  CAS  Google Scholar 

  • Kunkl, A., and Klaus, G. G. B., 1980, Selective effects of cyclosporin A on functional cell subsets in the mouse, J. Immunol. 125:2526–2531.

    PubMed  CAS  Google Scholar 

  • Laupacis, A., Stiller, C. R., Gardell, C., Keown, P., Dupré, J., Wallace, A. C., and Thibert, P., 1983, Cyclosporin prevents diabetes in BB Wistar rats, Lancet 1:10–12.

    Article  PubMed  CAS  Google Scholar 

  • Le Hoang, P., Girard, B., Deray, G., Le Minh, H., de Kozak, Y., Thillaye, B., Faure, J. P., and Rousselie, E., 1988, Cyclosporine in the treatment of birdshot retinochoroidopathy, Transplant. Proc. 20(Suppl. 4):128–130.

    PubMed  Google Scholar 

  • Lemaire, M., Maurer, G., and Wood, A. J., 1986, Pharmacokinetics and metabolism, Prog. Allergy 38:93–107.

    PubMed  CAS  Google Scholar 

  • Lichtiger, S., and Present, D. H. 1990, Preliminary report: Cyclosporin in treatment of severe active ulcerative colitis, Lancet 336:16–19.

    Article  PubMed  CAS  Google Scholar 

  • Ludwin, D., Bennett, K. J., Grau, E. M., Buchanan, W W., Bensen, W., Bombardier, C., and Tugwell, P. X., 1988, Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine, Transplant Proc. 20(Suppl. 4):367–370.

    PubMed  CAS  Google Scholar 

  • Masuda, K., Nakajima, A., Urayama, A., Nakae, K., Kogure, M., and Inaba, G., 1989, Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s disease, Lancet 1:1093–1096.

    Article  PubMed  CAS  Google Scholar 

  • McKeon, E., 1991, When worlds collide: Immunosuppressants meet protein phophatases, Cell 66:823–826.

    Article  PubMed  CAS  Google Scholar 

  • Meyrier, A., 1989, Treatment of glomerular disease with cyclosporin A, Nephrol. Dial Transplant. 4:923–931.

    PubMed  CAS  Google Scholar 

  • Meyrier, A., Simon, P., Perret, G., Condamin-Meyrier, M. C., 1986, Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A, Brit. Med. J. 292:789–792.

    Article  CAS  Google Scholar 

  • Miescher, P. A., Favre, H., Chatelanat, E., Mihatsch, M. J., 1987, Combined steroid-cyclosporin treatment of chronic autoimmune diseases, Klin. Wochenschr. 65:727–736.

    Article  PubMed  CAS  Google Scholar 

  • Miescher, P. A., Favre, H., Mihatsch, M. J., Chatelenat, E., Huang, Y. P., and Zubler, R., 1988, The place of cyclosporin A in the treatment of connective tissue diseases, Transplant. Proc. 20(Suppl. 4):224–237.

    PubMed  CAS  Google Scholar 

  • Mihatsch, M. J., 1985, International workshop in cyclosporine nephropathy, Clin. Nephrol. 24:107–119.

    Google Scholar 

  • Mihatsch, M. J., Bach, J. F., Coovadia, H. M., Forre, O., Mootsopoulos, H. M., Drosos, A. A., Siamopoulos, K. C., Noel, I. H., Ramsaroop, R., Hallgren, R., Svenson, K., and Bohman, S. O., 1988, Cyclosporin-associated nephropathy in patients with autoimmune diseases, Klin. Wochenschr. 66:43–47.

    Article  PubMed  CAS  Google Scholar 

  • Mori, Y., Suko, M., Okudaira, H., Matsuba, I., Tsuruoka, A., Sasaki, A., Yokoyama, H., Tanase, T., Shida, A., Nishimura, M., Terada, E., and Ikeda, Y., 1986, Preventive effect of cyclosporin in diabetes in NOD mice, Diabetobgia 29:244–247.

    Article  CAS  Google Scholar 

  • Mountz, J. D., Smith, H. R., Wilder, R. L., Reeves, J. P., and Steinberg, A. D., 1987, CS-A Therapy in MRL-lpr/lpr mice: Amelioration of immunopathology despite autoantibody production, J. Immunol. 138:157–163.

    PubMed  CAS  Google Scholar 

  • Müller, W., and Herrmann, B., 1979, Cyclosporin A for psoriasis, N. Engl. J. Med. 301:555.

    Google Scholar 

  • The Multiple Sclerosis Study Group, 1990, Efficacy and toxicity of Sandimmun in multiple sclerosis: A double-blind placebo-controlled study, Ann. Neurol 27:591–605.

    Article  Google Scholar 

  • Niaudet, P., Tete, M. J., Broyer, M., and Habib, R., 1988, Cyclosporin and childhood idiopathic nephrosis, Transplant. Proc. 20(Suppl. 4):265–268.

    PubMed  CAS  Google Scholar 

  • Nickoloff, B. J., Fischer, G. J., Mitra, R. S., and Voorhees, J. J., 1988, Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes, Am. J. Pathol. 131:12–18.

    PubMed  CAS  Google Scholar 

  • Niederberger, W., Lemaire, M., Maurer, G., Nussbaumer, K., and Wagner, O., 1983, Distribution and binding of cyclosporine in blood and tissues, Transplant Proc. 15(Suppl. 1):2419–2421.

    CAS  Google Scholar 

  • Nussenblatt, R. B., Rodgrigues, M. M., and Wacker, W. B., 1981, Cyclosporin A-inhibition of experimental auto-immune uveitis in Lewis rats, J. Clin. Invest. 67:1228–1231.

    Article  PubMed  CAS  Google Scholar 

  • Nussenblatt, R. B., Rook, A. H., Wacker, W. B., Palestine, A. G., Scher, I., and Gery, I., 1983, Treatment of intraocular inflammatory disease with cyclosporin A, Lancet 2:235.

    Article  PubMed  CAS  Google Scholar 

  • Palestine, A. G., Austin, H. A., Balow, J. E., Antonovych, T. T., Sabnis, S. G., Preuss, H. G., and Nussenblatt, R. B., 1986, Renal histopathologic alterations in patients treated with cyclosporin for uveitis, N. Engl. J. Med. 314:1293–1298.

    Article  PubMed  CAS  Google Scholar 

  • Routhier, G., Epstein, O., Janossy, G., Thomas, A. C., and Sherlock, S., 1980, Effects of cyclosporin A on suppressor and inducer T-lymphocytes in primary biliary cirrhosis, Lancet 2:1223–1225.

    Article  PubMed  CAS  Google Scholar 

  • Rubenstein, A. H., and Pyke, D., 1987, Immunosuppression in the treatment of insulin-dependent (type 1) diabetes, Lancet 1:436–437.

    Article  PubMed  CAS  Google Scholar 

  • Rudge, P., Koetsier, J. C., Mertin, J., Mispelblom-Beyer, J. O., van Walbeek, H. K., Clifford-Janes, R., Harrison, J., Robinson, K., Mellein, B., Poole, T., Stovkis, J. C. J. M., and Timonen, P., 1989, Randomized double-blind controlled trial of cyclosporin in multiple sclerosis, J. Neurol. Neurosurg. Psychiatr. 52:559–565.

    Article  PubMed  CAS  Google Scholar 

  • Ryffel, B., Foxwell, B. M. J., Mihatsch, M. J., Donatsch, P., and Maurer, G., 1988, Biological significance of cyclosporine metabolites, Transplant Proc. 20(Suppl. 2):575–584.

    PubMed  CAS  Google Scholar 

  • Sowden, J. M., Berth-Jones, J., Ross, J. S., Motley, R. J., Marks, R., Finlay, A. T., Salek, M. S., Graham-Brown, R. A. C., Allen, B. R., and Camp, R. D. R., 1991, Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis, Lancet 388: 137–140.

    Article  Google Scholar 

  • Stiller, R., Dupré, J., Gent, M., Jenner, M. R., Keown, P. A., Laupacis, A., Martell, R., Rodger, R., von Graffenried, B., and Wolfe, B. M. J., 1984, Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset, Science 223:1362–1367.

    Article  PubMed  CAS  Google Scholar 

  • Tejani, A., Butt, K., and Trachtman, H., 1988, Cyclosporin A induced remission of relapsing nephrotic syndrome in children, Kidney Int. 33:729–734.

    Article  PubMed  CAS  Google Scholar 

  • Thomson, A. W., Moon, D. K., Geczly, C. L., and Nelson, D. C., 1983, Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines, Immunology 48:291–299.

    PubMed  CAS  Google Scholar 

  • Thompson, C. B., June, C. H., Sullivan, E. M., and Thomas, E. D., 1984, Association between cyclosporine neurotoxicity and hypomagnesemia, Lancet 2:1116–1120.

    Article  PubMed  CAS  Google Scholar 

  • Timonen, P., Friend, D, Abeywickrama, K., Laburte, C., von Graffenried, B., and Feutren, G., 1990, Efficacy of low-dose cyclosporin A in psoriasis: Results of dose-finding studies, Br. J.J. Dermatol. 122(Suppl. 36):33–39.

    Article  Google Scholar 

  • Tindall, R. S. A., Rollins, J. A., Phillips, J. T., Greenlee, R. G., Wells, L., and Belendiuk, G., 1987, Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporin in myathenia gravis, N. Engl. J. Med. 316:719–724.

    Article  PubMed  CAS  Google Scholar 

  • Tugwell, P., Bombardier, C., Gent, M., Bennett, K. J., Bensen, W. G., Carette, S., Chalmers, A., Esdaile, J. M., Klinkhoff, A. V, Kraag, G. R., Ludwin, D., and Roberts, R. S., 1990, Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis, Lancet 355:1051–1055.

    Article  Google Scholar 

  • Urabe, A., Kanitakis, J., Viac, J., and Thivolet, J., 1989, Cyclosporin A inhibits directly m vivo keratinocyte proliferation of living human skin, J. Invest. Dermatol. 92:755–757.

    Article  PubMed  CAS  Google Scholar 

  • Van Hooff, J. P., Leunissen, K. M. L., Havenith, M. G., and Bosman, F. T., 1988, Cyclosporin and other therapy resistant nephrotic syndrome, Transplant. Proc. 20(Suppl. 4):293–296.

    PubMed  Google Scholar 

  • Van Joost, T., Stolz, E., and Heule, F., 1987, Efficacy of low-dose cyclosporin in severe atopic skin disease, Arch. Dermatol. 123: 166–167.

    Article  PubMed  Google Scholar 

  • Van Joost, T. H., Bos, J. D., Heule, F., and Meinardi, M. M. H. M., 1988, Low-dose cyclosporin A in severe psoriasis. A double-blind study, Br. J. Dermatol. 118:183–190.

    Article  PubMed  Google Scholar 

  • Van Rijthoven, A. W. A. M., Dijkmans, B. A. C., Goeithe, H. S., Hermans, J., Montnor-Beckers, Y. L. M. B., Jacobs, P. C. J., and Cats, A., 1986, Cyclosporin treatment for rheumatoid arthritis: A placebo controlled, double blind, multicentre study, Ann. Rheum. Dis. 45:726–731.

    Article  PubMed  Google Scholar 

  • Von Graffenried, B., and Krupp, P., 1986, Side effects of cyclosporine (Sandimmun) in renal transplant recipients and in patients with autoimmune diseases, Transplant Proc. 18:876–883.

    Google Scholar 

  • Weetman, A. P., McGregor, A. M., Ludgate, M., Beck, L., Mills, P. V, Lazarus, J. H., and Hall, R., 1983, Cyclosporin improves Graves’ ophthalmopathy, Lancet 2:486–489.

    Article  PubMed  CAS  Google Scholar 

  • Weinblatt, M., Coblyn, J. S., Fraser, P. A., Anderson, R. J., Spragg, J., Trentham, D. E., and Austen, K. F., 1987, Cyclosporin A treatment of refractory rheumatoid arthritis, Arthritis Rheum. 30:11–17.

    Article  PubMed  CAS  Google Scholar 

  • Wick, G., Müller, P. U., and Schwary, S., 1982, Effect of cyclosporin A on spontaneous auto-immune thyroiditis of obese strain (os) chickens, Eur. J. Immunol. 12:877–881.

    Article  PubMed  CAS  Google Scholar 

  • Wiesner, H., Ludwig, J., Lindor, D, Jorgensen, A., Baldus, P., Homburger, A., and Dickson, E., 1990, A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis, N. Engl. J. Med. 322:1419–1424.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research/Immunology, Sandoz Pharma Ltd, CH-4002, Basle, Switzerland

    Gilles Feutren & Beat von Graffenried

Authors
  1. Gilles Feutren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beat von Graffenried
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Pharmacology, The National Hospital, University of Oslo, N-0027, Oslo 1, Norway

    Hans Erik Rugstad

  2. Institute of Clinical Biochemistry, The National Hospital, University of Oslo, 0027, Oslo 1, Norway

    Liv Endresen

  3. Oslo Sanitetsforening Rheumatism Hospital, N-0172, Oslo 1, Norway

    Øystein Førre

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Feutren, G., von Graffenried, B. (1992). Cyclosporin A. In: Rugstad, H.E., Endresen, L., Førre, Ø. (eds) Immunopharmacology in Autoimmune Diseases and Transplantation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1167-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1167-4_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1169-8

  • Online ISBN: 978-1-4899-1167-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation